Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank92
3Y CAGR+11.1%
5Y CAGR+23.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+11.1%/yr
vs +29.9%/yr prior
5Y CAGR
+23.4%/yr
Recent deceleration
Acceleration
-18.8pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$36.60M-8.3%
2025$39.94M+33.4%
2024$29.94M+12.2%
2023$26.67M+28.6%
2022$20.74M+62.4%
2021$12.77M+28.1%
2020$9.97M+6.4%
2019$9.37M-34.1%
2018$14.23M-10.4%
2017$15.88M-